Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05579444 · ClinicalTrials.gov registry record

Systems Biology of Gastrointestinal and Related Diseases

A clinical trial, sponsored by Viome.

Terminated
Registry status
17
Enrollment target

NCT05579444 is a clinical trial that was terminated before completion, run by Viome. The registered enrollment target is 17 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05579444 was terminated before completion, sponsored by Viome.

TERMINATED
Registry status
17 participants
Enrollment target

Study Summary

This is a longitudinal observational study on patients with gastrointestinal and related disease. The study will be conducted for at least 10 years, following each participant over time, as they either go through relapses and remissions, or progression of their disease.

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2022-11-11
Est. Completion 2023-11-29

Sponsor

Viome

18 total trials

What the Registry Record Tells You About NCT05579444

The ClinicalTrials.gov registry entry for NCT05579444 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Viome, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT05579444 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05579444 about?

NCT05579444 is a clinical study titled "Systems Biology of Gastrointestinal and Related Diseases". This is a longitudinal observational study on patients with gastrointestinal and related disease. The study will be conducted for at least 10 years, following each participant over time, as they either go through relapses and remissions, or progression of their disease.

What is the current status of trial NCT05579444?

This trial is currently terminated. The enrollment target is 17 participants. The study started on 2022-11-11. Estimated completion is 2023-11-29.

Who is sponsoring clinical trial NCT05579444?

This trial is sponsored by Viome, which has 18 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.